Esbriet is a medicine used to treat adults with idiopathic pulmonary fibrosis (IPF). IPF is a long\-term disease in which fibrous scar tissue continuously forms in the lungs, causing persistent cough, frequent lung infections and severe shortness of breath. ‘Idiopathic’ means that the cause of the disease is unknown. Esbriet contains the active substance pirfenidone.
Therapeutic Indication
Esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
Therapeutic Area (MeSH)
ATC Code
L04AX05
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
EMA Name
Esbriet
Medicine Name
Esbriet
Aliases
N/ANo risk management plan link.
